Form 4 for BIIB Biogen
Accepted 2023-05-02 00:00:00 ET · period of report 2023-04-28 · accession 0001127602-23-014146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-02 | 2023-04-28 | BIIB | Gregory Ginger | EVP, Human Resources | S - Sale | $300.00 | -2,681 | 8,483 | -24% | -$804.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | S | D | 2,681 | $300.00 | 8,482.72 | D | — | — | (F1) Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2023. |